Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Insomnia
ADR ID BADD_A02362
ADR Hierarchy
17      Nervous system disorders
17.15      Sleep disturbances (incl subtypes)
17.15.03      Disturbances in initiating and maintaining sleep
17.15.03.002      Insomnia
19      Psychiatric disorders
19.02      Sleep disorders and disturbances
19.02.01      Disturbances in initiating and maintaining sleep
19.02.01.002      Insomnia
Description A disorder characterized by difficulty in falling asleep and/or remaining asleep. [CTCAE] Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition. [MeSH]
MedDRA Code 10022437
MeSH ID D007319; D007319; D007319
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Difficulty sleeping | Insomnia | Insomnia (non-organic) | Insomnia exacerbated | Insomnia NEC | Insomnia NOS | Insomnia related to another mental condition | Other insomnia | Persistent disorder of initiating or maintaining sleep | Primary insomnia | Sleep decreased | Sleep difficult | Sleep loss | Sleeplessness | Transient disorder of initiating or maintaining sleep | Chronic insomnia | Dysphylaxia | Transient insomnia | Agrypnia | Insomnia disorder | Short term insomnia | Secondary insomnia | Sleep Initiation and Maintenance Disorders | Disorders of Initiating and Maintaining Sleep | DIMS (Disorders of Initiating and Maintaining Sleep) | Early Awakening | Awakening, Early | Nonorganic Insomnia | Insomnia, Nonorganic | Primary Insomnia | Insomnia, Primary | Transient Insomnia | Insomnia, Transient | Rebound Insomnia | Insomnia, Rebound | Secondary Insomnia | Insomnia, Secondary | Sleep Initiation Dysfunction | Dysfunction, Sleep Initiation | Dysfunctions, Sleep Initiation | Sleep Initiation Dysfunctions | Insomnia Disorder | Insomnia Disorders | Insomnias | Chronic Insomnia | Insomnia, Chronic | Psychophysiological Insomnia | Insomnia, Psychophysiological
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D000064r,6r-dorzolamide--
BADD_D000075-tert-butyl-2-methyl-1,3-benzodioxole--
BADD_D00008Abacavir--
BADD_D00009Abacavir succinate--
BADD_D00014Abiraterone--
BADD_D00015Abiraterone acetate--
BADD_D00016Acamprosate--
BADD_D00017Acamprosate calcium--
BADD_D00019Acebutolol--
BADD_D00020Acebutolol hydrochloride--
BADD_D00023Acetaminophen0.000261%
BADD_D00025Acetazolamide--
BADD_D00029Acetyl sulfisoxazole--
BADD_D00036Acitretin--
BADD_D00039Acyclovir--
BADD_D00046Ado-trastuzumab emtansine--
BADD_D00047Afatinib--
BADD_D00050Agomelatine--
BADD_D00056Albuterol--
BADD_D00057Albuterol sulfate--
BADD_D00062Aldesleukin--
BADD_D00064Alemtuzumab--
BADD_D00066Alendronic acid0.002281%
BADD_D00073Aliskiren--
BADD_D00075Alitretinoin--
BADD_D00076Allopurinol--
BADD_D00077Almotriptan--
BADD_D00078Almotriptan malate--
BADD_D00085Alprazolam0.001211%
BADD_D00097Amantadine0.005739%
The 1th Page    1 2 3 4 5    Next   Last    Total 39 Pages
ADReCS-Target
ADR Term Drug Name Target